Inventor · disambiguated record
Daniel John Lightwood
Also filed as: LIGHTWOOD DANIEL JOHN
18 granted patents·12 pending applications·65 citations·filing 2003–2025
93Inventor score
Top patents by PatentIndex Score
30 records- 0193US11022614B2Antibodies binding to trimeric TNF alpha epitopesUCB Biopharma SRL·Filed 2015·Granted Jun 1, 2021·5 cites·17 claims
- 0293US10969393B2Complexes between anti-TNF antibodies, trimeric TNF proteins and organic molecules binding themUCB Biopharma SRL·Filed 2015·Granted Apr 6, 2021·5 cites·11 claims
- 0393US10775385B2Treatment of autoimmune and inflammatory disorders with asymmetric TNF alpha trimersUCB BIOPHARMA SPRL·Filed 2015·Granted Sep 15, 2020·7 cites·4 claims
- 0492US11674967B2Method of identifying potential inhibitors of APO TNFα trimersUCB Biopharma SRL·Filed 2020·Granted Jun 13, 2023·2 cites·19 claims
- 0588US12055549B2Methods of use of anti-TNFα antibodiesUCB Biopharma SRL·Filed 2021·Granted Aug 6, 2024·1 cites·16 claims
- 0688US11261242B2Anti-alpha-synuclein antibodiesUCB Biopharma SRL·Filed 2018·Granted Mar 1, 2022·3 cites·21 claims
- 0786US11174311B2Antibody against trimeric TNFα complexUCB Biopharma SRL·Filed 2017·Granted Nov 16, 2021·4 cites·14 claims
- 0886US7993864B2Assay for identifying antibody producing cellsUCB PHARMA SA·Filed 2003·Granted Aug 9, 2011·20 cites·17 claims
- 0981US9957320B2Isolated DNA sequences encoding, and methods for making, antibody molecules having binding specificity for human IL-13UCB BIOPHARMA SPRL·Filed 2016·Granted May 1, 2018·3 cites·8 claims
- 1080US9394361B2Isolated DNA sequences encoding, and methods for making, antibody molecules having binding specificity for human IL-13UCB PHARMA SA·Filed 2014·Granted Jul 19, 2016·4 cites·9 claims
- 1179US8691233B2Antibody molecules having binding specificity for human IL-13GOZZARD NEIL·Filed 2010·Granted Apr 8, 2014·7 cites·12 claims
- 1277US2021132079A1AntibodyUCB Biopharma SRL·Filed 2021·Application pending·0 cites
- 1376US2025270308A1Antibody epitopeUCB Biopharma SRL·Filed 2025·Application pending·0 cites
- 1474US11292831B2Anti-alpha synuclein antibodiesUCB Biopharma SRL·Filed 2018·Granted Apr 5, 2022·1 cites·21 claims
- 1574US10766956B2Antagonist antibodies that bind to human TGFB1, TGFB2 and to TGFB3 and their use for the treatment of lung fibrosisUCB BIOPHARMA SPRL·Filed 2017·Granted Sep 8, 2020·1 cites·11 claims
- 1673US7790414B2Methods for producing antibodiesUCB PHARMA SA·Filed 2004·Granted Sep 7, 2010·2 cites·9 claims
- 1769US2022025033A1Antibody epitopeUCB Biopharma SRL·Filed 2021·Application pending·0 cites
- 1863US12410244B2Anti-alpha-synuclein antibodiesUCB Biopharma SRL·Filed 2022·Granted Sep 9, 2025·0 cites·15 claims
- 1959US2024409624A1AntibodiesUCB Biopharma SRL·Filed 2022·Application pending·0 cites
- 2058US11518803B2Antagonist antibodies that bind to human TGFB1, TGFB2 and to TGFB3 and their use for the treatment of lung fibrosisUCB Biopharma SRL·Filed 2020·Granted Dec 6, 2022·0 cites·20 claims
- 2155US2024254224A1AntibodiesUCB Biopharma SRL·Filed 2022·Application pending·0 cites
- 2253US2020377578A1Neutralising antibodies to the major exotoxins tcda and tcdb of clostridium difficileUCB BIOPHARMA SPRL·Filed 2020·Application pending·0 cites
- 2352US2021262024A1Polynucleotide duplex probe moleculeUCB Biopharma SRL·Filed 2019·Application pending·0 cites
- 2452US2023084464A1Antibody with binding specificity for human il-13UCB Biopharma SRL·Filed 2020·Application pending·0 cites
- 2551US10752676B2Neutralising antibodies to the major exotoxins TCDA and TCDB of Clostridium difficileHUMPHREYS DAVID PAUL·Filed 2012·Granted Aug 25, 2020·0 cites·43 claims
- 2651US2024067758A1Multi-specific antibodies and antibody combinationsUCB Biopharma SRL·Filed 2021·Application pending·0 cites
- 2750US2023176071A1Arrays and methods for identifying binding sites on a proteinUCB Biopharma SRL·Filed 2021·Application pending·0 cites
- 2849US11091542B2Antibody molecules which bind TNF alphaUCB Biopharma SRL·Filed 2016·Granted Aug 17, 2021·0 cites·22 claims
- 2939US2016159922A1Novel Antibodies for the Diagnosis and Treatment of Rheumatoid ArthritisVILARA AB·Filed 2014·Application pending·0 cites
- 3038US2020277366A1MULTI-SPECIFIC ANTIBODY MOLECULES HAVING SPECIFICITY FOR TNF-ALPHA, IL-17A and IL-17FUCB BIOPHRMA SPRL·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daniel John Lightwood files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →